Study protocol of a phase II clinical trial evaluating the efficacy of neoadjuvant intraperitoneal and systemic albumin-bound paclitaxel combined with camrelizumab and S-1 in the treatment of patients with exfoliative cell-positive gastric cancer

BACKGROUND: Currently, gastric cancer with positive lavage cytology without gross peritoneal dissemination (GC-CY1) is a special type of metastatic form with poor prognosis. Consensus guidelines on treatment strategies for patients with GC-CY1 have not been established. This study involves a single-...

Descripción completa

Detalles Bibliográficos
Autores principales: Lv, Jingxia, Wu, Jiaxiang, Wu, Haotian, Ding, Ping’an, Guo, Honghai, Yang, Peigang, Tian, Yuan, Liu, Yang, Zhao, Qun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571916/
https://www.ncbi.nlm.nih.gov/pubmed/37841441
http://dx.doi.org/10.3389/fonc.2023.1201928

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571916/
https://www.ncbi.nlm.nih.gov/pubmed/37841441
http://dx.doi.org/10.3389/fonc.2023.1201928

Ejemplares similares